Why the study?
Does the immunoglobulin isotype of antimyosin antibodies determine their pathogenicity in inducing autoimmune myocarditis in naive mice?
Does the immunoglobulin isotype of antimyosin antibodies determine their pathogenicity in inducing autoimmune myocarditis in naive mice?
Antimyosin antibodies require class switching to the IgG isotype to penetrate cardiac tissue and induce autoimmune myocarditis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IgG isotype targeting in myocarditis; leaves open human translation from this animal model.
Antimyosin reactivity is associated with cardiac damage in autoimmune myocarditis, an inflammatory heart disease characterized by a cellular infiltrate in the myocardium and myocyte necrosis. We are interested in the pathogenicity of antimyosin antibodies and their ability to cause autoimmune myocarditis. We have shown that antimyosin antibodies of the IgG isotype will induce disease in the DBA/2 mouse. In the present study, we show that IgM antimyosin antibodies do not induce myocarditis; however, these same antibodies become pathogenic when converted to the IgG isotype. Although IgM antibodies can penetrate the myocardium during cardiac inflammation, they are usually less able to leave the vascular compartment and penetrate cardiac tissue, thus accounting for their lack of pathogenicity. Thus, antimyosin B cells may be potentially pathogenic only after antigen activation and heavy chain class switching or under conditions that alter vascular permeability in the heart.
No takes yet. Share an insight, caveat, or question.
Kuan et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: